{"id":"NCT00321919","sponsor":"Hoffmann-La Roche","briefTitle":"A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia","officialTitle":"A Randomized, Open-label Study of the Effect of NeoRecormon on Reduction of Cardiovascular Risk in Patients With Chronic Renal Anemia Who Are Not on Renal Replacement Therapy.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2000-07","primaryCompletion":"2004-10","completion":"2004-12","firstPosted":"2006-05-04","resultsPosted":"2016-05-25","lastUpdate":"2016-06-29"},"enrollment":605,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Anemia"],"interventions":[{"type":"DRUG","name":"epoetin beta [NeoRecormon]","otherNames":[]},{"type":"DRUG","name":"epoetin beta [NeoRecormon]","otherNames":[]}],"arms":[{"label":"Early Epoetin Beta Therapy","type":"EXPERIMENTAL"},{"label":"Late Epoetin Beta Therapy","type":"ACTIVE_COMPARATOR"}],"summary":"This study will evaluate whether anemia prevention with NeoRecormon has an additional impact on reducing cardiovascular risk over conventional anemia treatment in patients mostly with stage IV chronic kidney disease and renal anemia. The anticipated time on study treatment is 2+ years and the target sample size is 500+ individuals.","primaryOutcome":{"measure":"Median Time to First Cardiovascular Event","timeFrame":"Up to 4 years","effectByArm":[{"arm":"Early Epoetin Beta Therapy","deltaMin":null,"sd":null},{"arm":"Late Epoetin Beta Therapy","deltaMin":null,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.2036"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":5},"locations":{"siteCount":93,"countries":["Austria","Belgium","Czechia","Denmark","Finland","France","Germany","Greece","Hong Kong","Ireland","Italy","Mexico","Norway","Poland","Portugal","Russia","Spain","Sweden","Taiwan","Thailand","Turkey (TÃ¼rkiye)","United Kingdom"]},"refs":{"pmids":["36791280","20849244","17108342"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":158,"n":300},"commonTop":["Renal Failure","Hypertension","Renal Failure Chronic","Hyperkalaemia","Urinary tract infection"]}}